Dose-escalation Study of Oral CX-4945
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Advanced Solid Tumors|Breast Cancer|Inflammatory Breast Cancer|Castleman's Disease|Multiple Myeloma
Interventions: DRUG: CX-4945 oral formulation
Sponsor: Cylene Pharmaceuticals